KR0149275B1 - Medicaments for the treatment of cerebral apoplexy - Google Patents
Medicaments for the treatment of cerebral apoplexyInfo
- Publication number
- KR0149275B1 KR0149275B1 KR1019970061359A KR19970061359A KR0149275B1 KR 0149275 B1 KR0149275 B1 KR 0149275B1 KR 1019970061359 A KR1019970061359 A KR 1019970061359A KR 19970061359 A KR19970061359 A KR 19970061359A KR 0149275 B1 KR0149275 B1 KR 0149275B1
- Authority
- KR
- South Korea
- Prior art keywords
- medicaments
- treatment
- cerebral apoplexy
- apoplexy
- cerebral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3831888A DE3831888A1 (en) | 1988-09-20 | 1988-09-20 | MEDICINES FOR TREATING APOPLEXIA CEREBRI |
| KR1019890013434A KR0135307B1 (en) | 1988-09-20 | 1989-09-19 | Medicaments for the treatment of cerebral apoplexy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR0149275B1 true KR0149275B1 (en) | 1998-10-15 |
Family
ID=25872381
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019970061359A KR0149275B1 (en) | 1988-09-20 | 1997-11-20 | Medicaments for the treatment of cerebral apoplexy |
| KR1019970061361A KR0149274B1 (en) | 1988-09-20 | 1997-11-20 | Medicaments for the treatment of cerebral apoplexy |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019970061361A KR0149274B1 (en) | 1988-09-20 | 1997-11-20 | Medicaments for the treatment of cerebral apoplexy |
Country Status (1)
| Country | Link |
|---|---|
| KR (2) | KR0149275B1 (en) |
-
1997
- 1997-11-20 KR KR1019970061359A patent/KR0149275B1/en not_active IP Right Cessation
- 1997-11-20 KR KR1019970061361A patent/KR0149274B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR0149274B1 (en) | 1998-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2188234B (en) | Therapeutic agents | |
| EP0385517A3 (en) | Medicaments for the treatment of emesis | |
| GB8719367D0 (en) | Therapeutic compounds | |
| ZA874251B (en) | Therapeutic agent for skin ulcers | |
| GB8725939D0 (en) | Therapeutic compounds | |
| GB2220352B (en) | Medicaments for the treatment of emesis | |
| GB8629568D0 (en) | Therapeutic agent | |
| GB2216414B (en) | Medicaments for the treatment of emesis | |
| EP0343671A3 (en) | Pharmaceutical composition for the treatment of skin wounds | |
| KR0149274B1 (en) | Medicaments for the treatment of cerebral apoplexy | |
| GB8720219D0 (en) | Therapeutic agent | |
| GB8626296D0 (en) | Therapeutic agents | |
| GB8603447D0 (en) | Therapeutic compounds | |
| GB8724564D0 (en) | Therapeutic compounds | |
| EP0272929A3 (en) | Enkephalinase for therapeutic use | |
| EP0412938A3 (en) | System for the treatment of contactlenses | |
| IE883710L (en) | Medicaments for the treatment of anxiety | |
| GB8629663D0 (en) | Therapeutic agents | |
| GB8529885D0 (en) | Therapeutic agent | |
| IE863048L (en) | Therapeutic agent | |
| GB8604611D0 (en) | Therapeutic agent | |
| GR3003007T3 (en) | Process for the treatment of alpha-calciumsulphate-hemihydrate | |
| GB8703900D0 (en) | Therapeutic agent | |
| RO92740B1 (en) | Medicinal composition for the treatment of otites | |
| GB8809045D0 (en) | Therapeutic agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A107 | Divisional application of patent | ||
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 20050524 Year of fee payment: 8 |
|
| LAPS | Lapse due to unpaid annual fee |